Product Description
VEGFR2 Antibody [KDR721] | 33-161 | ProSci
Host: Mouse
Reactivity: Human
Homology: N/A
Immunogen: Recombinant human VEGFR2 protein was used as the immunogen for this antibody.
Research Area: Cancer, Immunology, Obesity, Signal Transduction
Tested Application: Flow, IF, Func
Application: Functional testing: order BSA/azide-free format
Flow Cytometry: 0.5-1 ug/million cells
IF: 0.5-1 ug/ml
Variations in protocols, secondaries and substrates may require the VEGFR2 antibody to be titered for optimal performance.
Specificiy: N/A
Positive Control 1: N/A
Positive Control 2: N/A
Positive Control 3: N/A
Positive Control 4: N/A
Positive Control 5: N/A
Positive Control 6: N/A
Molecular Weight: N/A
Validation: N/A
Isoform: N/A
Purification: Protein G affinity chromatography
Clonality: Monoclonal
Clone: KDR721
Isotype: IgG1, kappa
Conjugate: Unconjugated
Physical State: Liquid
Buffer: PBS with 0.1 mg/ml BSA and 0.05% sodium azide
Concentration: 0.2 mg/mL
Storage Condition: Aliquot and Store at 2-8˚C. Avoid freez-thaw cycles.
Alternate Name: Vascular endothelial growth factor receptor 2, VEGFR-2, Fetal liver kinase 1, FLK-1, Kinase insert domain receptor, KDR, Protein-tyrosine kinase receptor flk-1, CD309, KDR, FLK1, VEGFR2
User Note: Optimal dilutions for each application to be determined by the researcher
BACKGROUND: VEGFR2 ( also called CD309, KDR3, and Flk-1) is a type I transmembrane glycoprotein and is mainly expressed by endothelial cells, embryonic tissues, and megakaryocytes. As a receptor for VEGF proteins, it plays an important role in the regulation of angiogenesis, vasculogenesis, and vascular permeability.